Try the Demo today!
| SEC Filing | Insider | Company | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Return |
|---|---|---|---|---|---|---|---|---|---|
| 03-Apr-24 6:05 PM View:  | Hamilton James C Chief Discovery/Trans Medicine | Arrowhead Research Corp. (ARWR) | 01-Apr-24 | Sale | 6,000 | $28.03 | $168,180.00 | (3%) 210.85K to 204.85K | |
| 20-Mar-24 7:06 PM View: | Lu Hongbo Director | Arrowhead Research Corp. (ARWR) | 20-Mar-24 | Purchase | 1,000 | $27.50 | $27,500.00 | 3% 32.68K to 33.68K | |
| 20-Mar-24 7:06 PM View: | Lu Hongbo Director | Arrowhead Research Corp. (ARWR) | 19-Mar-24 | Purchase | 1,000 | $28.00 | $28,000.00 | 3% 31.68K to 32.68K | |
| 20-Mar-24 7:06 PM View: | Lu Hongbo Director | Arrowhead Research Corp. (ARWR) | 18-Mar-24 | Private Purchase | 1,000 | $27.49 | $27,490.00 | 3% 30.68K to 31.68K | |
| 08-Mar-24 5:54 PM View: | Myszkowski Kenneth Allen Chief Financial Officer | Arrowhead Research Corp. (ARWR) | 06-Mar-24 | Sale | 40,000 | $35.19 | $1,407,600.00 | (9%) 440.6K to 400.6K | |
| 02-Feb-24 5:25 PM View: | Anzalone Christopher Richard Chief Executive Officer Director | Arrowhead Research Corp. (ARWR) | 31-Jan-24 | Option Exercise | 57,499 | $14.54 | $836,035.00 | 2% 3.72M to 3.77M | |
| 02-Feb-24 5:25 PM View: | Anzalone Christopher Richard Chief Executive Officer Director | Arrowhead Research Corp. (ARWR) | 31-Jan-24 | Planned Option Sale | 57,499 | $32.35 | $1,860,020.00 | (2%) 3.77M to 3.72M | |
| 17-Jan-24 6:32 PM View: | Hamilton James C Chief Discovery/Trans Medicine | Arrowhead Research Corp. (ARWR) | 12-Jan-24 | Sale (Planned) | 7,940 | $36.89 | $292,904.00 | (4%) 218.79K to 210.85K | |
| 16-Jan-24 6:06 PM View: | Ferrari Mauro Director | Arrowhead Research Corp. (ARWR) | 11-Jan-24 | Sale (Planned) | 3,147 | $38.06 | $119,787.00 | (5%) 63.92K to 60.78K | |
| 16-Jan-24 6:06 PM View: | Vakiener Victoria Director | Arrowhead Research Corp. (ARWR) | 11-Jan-24 | Sale (Planned) | 4,720 | $38.10 | $179,813.00 | (13%) 36.72K to 32.0K | |
| 16-Jan-24 6:06 PM View: | Given Douglas B Director | Arrowhead Research Corp. (ARWR) | 11-Jan-24 | Sale (Planned) | 2,911 | $38.06 | $110,788.00 | (2%) 132.62K to 129.71K | |
| 16-Jan-24 6:06 PM View: | Waddill William D. Director | Arrowhead Research Corp. (ARWR) | 11-Jan-24 | Sale (Planned) | 3,934 | $38.07 | $149,759.00 | (8%) 51.8K to 47.87K | |
| 05-Jan-24 8:02 PM View: | Hamilton James C | Arrowhead Research Corp. (ARWR) | 05-Jan-24 | Sale (Planned) | 32,143 | $35.18 | $1,130,750.00 | (13%) 250.93K to 218.79K | |
| 05-Jan-24 7:58 PM View: | O'Brien Patrick COO and General Counsel | Arrowhead Research Corp. (ARWR) | 05-Jan-24 | Sale (Planned) | 22,841 | $35.28 | $805,716.00 | (5%) 487.23K to 464.38K | |
| 08-Jan-24 5:16 PM View: | Myszkowski Kenneth Allen Chief Financial Officer | Arrowhead Research Corp. (ARWR) | 05-Jan-24 | Sale (Planned) | 16,104 | $35.27 | $567,910.00 | (4%) 456.7K to 440.6K | |
| 08-Jan-24 5:17 PM View: | Oliver Tracie Chief Commercial Officer | Arrowhead Research Corp. (ARWR) | 05-Jan-24 | Sale (Planned) | 74 | $33.89 | $2,507.86 | (< 1%) 136.57K to 136.5K | |
| 08-Jan-24 5:16 PM View: | San Martin Javier Chief Medical Officer | Arrowhead Research Corp. (ARWR) | 05-Jan-24 | Sale (Planned) | 8,303 | $35.26 | $292,804.00 | (4%) 206.8K to 198.5K | |
| 05-Jan-24 7:58 PM View: | O'Brien Patrick COO and General Counsel | Arrowhead Research Corp. (ARWR) | 04-Jan-24 | Grant | 85,000 | -- | -- | 21% 403.83K to 488.83K | |
| 08-Jan-24 5:16 PM View: | San Martin Javier Chief Medical Officer | Arrowhead Research Corp. (ARWR) | 04-Jan-24 | Grant | 75,000 | -- | -- | 57% 131.8K to 206.8K | |
| 08-Jan-24 5:16 PM View: | Myszkowski Kenneth Allen Chief Financial Officer | Arrowhead Research Corp. (ARWR) | 04-Jan-24 | Grant | 75,000 | -- | -- | 20% 381.7K to 456.7K | |
| 05-Jan-24 8:02 PM View: | Hamilton James C | Arrowhead Research Corp. (ARWR) | 04-Jan-24 | Grant | 75,000 | -- | -- | 43% 175.93K to 250.93K | |
| 08-Jan-24 5:17 PM View: | Oliver Tracie Chief Commercial Officer | Arrowhead Research Corp. (ARWR) | 04-Jan-24 | Grant | 75,000 | -- | -- | 122% 61.58K to 136.57K | |
| 05-Jan-24 7:58 PM View: | O'Brien Patrick COO and General Counsel | Arrowhead Research Corp. (ARWR) | 04-Jan-24 | Sale (Planned) | 1,600 | $32.63 | $52,208.00 | (< 1%) 488.83K to 487.23K | |
| 05-Jan-24 7:58 PM View: | O'Brien Patrick COO and General Counsel | Arrowhead Research Corp. (ARWR) | 03-Jan-24 | Sale (Planned) | 8,749 | $32.28 | $282,439.00 | (2%) 412.57K to 403.83K | |
| 05-Jan-24 8:02 PM View: | Hamilton James C | Arrowhead Research Corp. (ARWR) | 03-Jan-24 | Sale (Planned) | 6,300 | $32.19 | $202,781.00 | (3%) 182.23K to 175.93K | |
| 04-Jan-24 5:25 PM View: | Anzalone Christopher Richard Chief Executive Officer Director | Arrowhead Research Corp. (ARWR) | 02-Jan-24 | Sale (Planned) | 9,952 | $31.01 | $308,637.00 | (< 1%) 3.73M to 3.72M | |
| 22-Dec-23 5:04 PM View: | Anzalone Christopher Richard Chief Executive Officer Director | Arrowhead Research Corp. (ARWR) | 20-Dec-23 | Sale (Planned) | 12,000 | $28.54 | $342,480.00 | (< 1%) 3.74M to 3.73M | |
| 19-Dec-23 4:03 PM View: | Ferrari Mauro Director | Arrowhead Research Corp. (ARWR) | 15-Dec-23 | Grant | 14,987 | $25.41 | $380,820.00 | 29% 50.84K to 65.83K | |
| 19-Dec-23 3:52 PM View: | Vakiener Victoria Director | Arrowhead Research Corp. (ARWR) | 15-Dec-23 | Grant | 14,987 | $25.41 | $380,820.00 | 69% 21.73K to 36.72K | |
| 19-Dec-23 3:54 PM View: | Olukotun Adeoye Y Director | Arrowhead Research Corp. (ARWR) | 15-Dec-23 | Grant | 14,987 | $25.41 | $380,820.00 | 191% 7.87K to 22.85K | |
| 19-Dec-23 3:55 PM View: | Perry Michael S Director | Arrowhead Research Corp. (ARWR) | 15-Dec-23 | Grant | 14,987 | $25.41 | $380,820.00 | 15% 99.77K to 114.75K | |
| 19-Dec-23 3:51 PM View: | Given Douglas B Director | Arrowhead Research Corp. (ARWR) | 15-Dec-23 | Grant | 14,987 | $25.41 | $380,820.00 | 13% 117.64K to 132.62K | |
| 19-Dec-23 3:41 PM View: | Waddill William D. Director | Arrowhead Research Corp. (ARWR) | 15-Dec-23 | Grant | 14,987 | $25.41 | $380,820.00 | 41% 36.82K to 51.8K | |
| 22-Nov-23 2:31 PM View: | San Martin Javier Chief Medical Officer | Arrowhead Research Corp. (ARWR) | 20-Nov-23 | Sale | 19,700 | $28.80 | $567,315.00 | (13%) 151.5K to 131.8K | |
| 27-Oct-23 6:23 PM View: | Anzalone Christopher Richard Chief Executive Officer Director | Arrowhead Research Corp. (ARWR) | 25-Oct-23 | Sale (Planned) | 24,338 | $24.21 | $589,223.00 | (< 1%) 3.76M to 3.74M | |
| 20-Sep-23 6:10 PM View: | Anzalone Christopher Richard Chief Executive Officer Director | Arrowhead Research Corp. (ARWR) | 18-Sep-23 | Option Exercise | 57,755 | $4.75 | $274,336.00 | 2% 3.76M to 3.82M | |
| 20-Sep-23 6:10 PM View: | Anzalone Christopher Richard Chief Executive Officer Director | Arrowhead Research Corp. (ARWR) | 18-Sep-23 | Planned Option Sale | 57,755 | $28.12 | $1,624,220.00 | (2%) 3.82M to 3.76M | |
| 06-Jul-23 6:04 PM View: | Oliver Tracie Chief Commercial Officer | Arrowhead Research Corp. (ARWR) | 03-Jul-23 | Sale | 8,925 | $35.31 | $315,142.00 | (13%) 70.5K to 61.58K | |
| 05-Jul-23 10:00 PM View: | Hamilton James C | Arrowhead Research Corp. (ARWR) | 30-Jun-23 | Sale | 3,000 | $35.53 | $106,590.00 | (2%) 191.48K to 188.48K | |
| 29-Jun-23 6:41 PM View: | Myszkowski Kenneth Allen Chief Financial Officer | Arrowhead Research Corp. (ARWR) | 27-Jun-23 | Sale | 15,000 | $36.20 | $543,000.00 | (4%) 396.7K to 381.7K | |
| 08-May-23 6:29 PM View: | Given Douglas B Director | Arrowhead Research Corp. (ARWR) | 05-May-23 | Sale | 6,500 | $40.90 | $265,850.00 | (4%) 149.63K to 143.13K | |
| 05-May-23 7:04 PM View: | Anzalone Christopher Richard Chief Executive Officer Director | Arrowhead Research Corp. (ARWR) | 04-May-23 | Option Exercise | 50,000 | $2.01 | $100,500.00 | 1% 3.76M to 3.81M | |
| 05-May-23 7:04 PM View: | Anzalone Christopher Richard Chief Executive Officer Director | Arrowhead Research Corp. (ARWR) | 04-May-23 | Option Sale | 50,000 | $39.52 | $1,975,790.00 | (1%) 3.81M to 3.76M | |
| 05-May-23 7:04 PM View: | Anzalone Christopher Richard Chief Executive Officer Director | Arrowhead Research Corp. (ARWR) | 03-May-23 | Option Exercise | 54,928 | $2.01 | $110,405.00 | 1% 3.76M to 3.82M | |
| 05-May-23 7:04 PM View: | Anzalone Christopher Richard Chief Executive Officer Director | Arrowhead Research Corp. (ARWR) | 03-May-23 | Option Sale | 54,928 | $39.14 | $2,149,880.00 | (1%) 3.82M to 3.76M | |
| 06-Mar-23 6:04 PM View: | Olukotun Adeoye Y Director | Arrowhead Research Corp. (ARWR) | 03-Mar-23 | Sale | 11,350 | $32.65 | $370,578.00 | (59%) 19.22K to 7.87K | |
| 01-Mar-23 6:14 PM View: | Given Douglas B Director | Arrowhead Research Corp. (ARWR) | 27-Feb-23 | Sale | 875 | $32.62 | $28,542.50 | (< 1%) 150.51K to 149.63K | |
| 11-Jan-23 8:35 PM View: | Vakiener Victoria Director | Arrowhead Research Corp. (ARWR) | 10-Jan-23 | Grant | 7,867 | -- | -- | 46% 17.18K to 25.05K | |
| 11-Jan-23 8:27 PM View: | Given Douglas B Director | Arrowhead Research Corp. (ARWR) | 10-Jan-23 | Grant | 7,867 | -- | -- | 7% 116.27K to 124.14K | |
| 11-Jan-23 8:17 PM View: | Olukotun Adeoye Y Director | Arrowhead Research Corp. (ARWR) | 10-Jan-23 | Grant | 7,867 | -- | -- | 69% 11.35K to 19.22K |
